Literature DB >> 32847938

An IL6-Adenosine Positive Feedback Loop between CD73+ γδTregs and CAFs Promotes Tumor Progression in Human Breast Cancer.

Guoming Hu1, Pu Cheng2,3, Jun Pan2, Shimin Wang4, Qiannan Ding5, Zhou Jiang2, Lu Cheng6, Xuan Shao2,7, Liming Huang1, Jian Huang8,7,9.   

Abstract

The tumor microenvironment induces immunosuppression via recruiting and expanding suppressive immune cells such as regulatory T cells (Treg) to promote cancer progression. In this study, we documented that tumor-infiltrating CD73+ γδTregs were the predominant Tregs in human breast cancer and exerted more potent immunosuppressive activity than CD4+ or CD8+ Tregs. We further demonstrated that cancer-associated fibroblast (CAF)-derived IL6, rather than TGFβ1, induced CD73+ γδTreg differentiation from paired normal breast tissues via the IL6/STAT3 pathway to produce more adenosine and become potent immunosuppressive T cells. CD73+ γδTregs could in turn promote IL6 secretion by CAFs through adenosine/A2BR/p38MAPK signaling, thereby forming an IL6-adenosine positive feedback loop. CD73+ γδTreg infiltration also impaired the tumoricidal functions of CD8+ T cells and significantly correlated with worse prognosis of patients. The data indicate that the IL6-adenosine loop between CD73+ γδTregs and CAFs is important to promote immunosuppression and tumor progression in human breast cancer, which may be critical for tumor immunotherapy. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32847938     DOI: 10.1158/2326-6066.CIR-19-0923

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  10 in total

Review 1.  Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects.

Authors:  Azam Bozorgi; Maryam Bozorgi; Mozafar Khazaei
Journal:  Cell Oncol (Dordr)       Date:  2022-08-09       Impact factor: 7.051

Review 2.  Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy.

Authors:  Yuan Song; Yonghao Liu; Huey Yee Teo; Haiyan Liu
Journal:  Front Immunol       Date:  2022-06-07       Impact factor: 8.786

3.  Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma.

Authors:  Zhi-Yong Shi; Sheng-Xiao Zhang; Di Fan; Cai-Hong Li; Zhe-Hao Cheng; Yan Xue; Li-Xiang Wu; Ke-Yi Lu; Su-Yun Yang; Yan Cheng; Zhi-Fang Wu; Chong Gao; Xiao-Feng Li; Hai-Yan Liu; Si-Jin Li
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 4.  Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity.

Authors:  Lilian Koppensteiner; Layla Mathieson; Richard A O'Connor; Ahsan R Akram
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

5.  PDGFR-β+ fibroblasts deteriorate survival in human solid tumors: a meta-analysis.

Authors:  Guoming Hu; Liming Huang; Kefang Zhong; Liwei Meng; Feng Xu; Shimin Wang; Tao Zhang
Journal:  Aging (Albany NY)       Date:  2021-05-03       Impact factor: 5.682

Review 6.  The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.

Authors:  Umar Mehraj; Rais A Ganai; Muzafar A Macha; Abid Hamid; Mohammed A Zargar; Ajaz A Bhat; Mohd Wasim Nasser; Mohammad Haris; Surinder K Batra; Bader Alshehri; Raid Saleem Al-Baradie; Manzoor A Mir; Nissar Ahmad Wani
Journal:  Cell Oncol (Dordr)       Date:  2021-09-16       Impact factor: 6.730

Review 7.  CD73, Tumor Plasticity and Immune Evasion in Solid Cancers.

Authors:  Haitang Yang; Feng Yao; Paul F Davis; Swee T Tan; Sean R R Hall
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

8.  A Comprehensive Investigation to Reveal the Relationship Between Plasmacytoid Dendritic Cells and Breast Cancer by Multiomics Data Analysis.

Authors:  Saisai Tian; Li Yan; Lu Fu; Zhen Zhang; Jinbo Zhang; Guofeng Meng; Weidong Zhang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 9.  [Research Status of Tumor-associated Fibroblasts Regulating Immune Cells].

Authors:  Guang Mu; Wenhao Zhang; Jingjing Huang; Zhipeng Chen; Jun Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-03-20

10.  NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.

Authors:  Xue-Min Chen; Yu-Yang Liu; Bing-Yan Tao; Xin-Miao Xue; Xin-Xin Zhang; Lin-Lin Wang; Hui Zhong; Jun Zhang; Shi-Ming Yang; Qing-Qing Jiang
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.